音量 3, 問題 1 (2013)
臨床試験の方法論
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Sunita Venkateswaran, Brenda Banwell
臨床試験の見通し
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
レビュー: 臨床試験の結果
Targeted therapy for hepatocellular carcinoma: current status and future direction
Stephen L Chan, Tony Mok
レビュー: 臨床試験の結果
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
研究の最新情報
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
方法論
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
